JP2017531665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017531665A5 JP2017531665A5 JP2017519568A JP2017519568A JP2017531665A5 JP 2017531665 A5 JP2017531665 A5 JP 2017531665A5 JP 2017519568 A JP2017519568 A JP 2017519568A JP 2017519568 A JP2017519568 A JP 2017519568A JP 2017531665 A5 JP2017531665 A5 JP 2017531665A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- zinc
- copper
- complex
- iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14187885.0 | 2014-10-07 | ||
| EP14187885.0A EP3006045B3 (en) | 2014-10-07 | 2014-10-07 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs |
| PCT/EP2015/073196 WO2016055550A1 (en) | 2014-10-07 | 2015-10-07 | Pharmaceutical formulations for the oral delivery of peptide or protein drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017531665A JP2017531665A (ja) | 2017-10-26 |
| JP2017531665A5 true JP2017531665A5 (https=) | 2018-11-15 |
Family
ID=51751911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017519568A Pending JP2017531665A (ja) | 2014-10-07 | 2015-10-07 | ペプチド又はタンパク質薬物を経口送達するための医薬製剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20170304195A1 (https=) |
| EP (2) | EP3006045B3 (https=) |
| JP (1) | JP2017531665A (https=) |
| KR (1) | KR20170061140A (https=) |
| CN (1) | CN106794252A (https=) |
| AU (1) | AU2015330016A1 (https=) |
| BR (1) | BR112017006957A2 (https=) |
| CA (1) | CA2960334A1 (https=) |
| DK (1) | DK3006045T3 (https=) |
| ES (1) | ES2630106T3 (https=) |
| IL (1) | IL251462A0 (https=) |
| MX (1) | MX2017004592A (https=) |
| RU (1) | RU2017115651A (https=) |
| SG (1) | SG11201702813VA (https=) |
| WO (1) | WO2016055550A1 (https=) |
| ZA (1) | ZA201701719B (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2630106T3 (es) | 2014-10-07 | 2017-08-18 | Cyprumed Gmbh | Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos |
| JP2018529749A (ja) | 2015-10-07 | 2018-10-11 | シプルメット・ゲーエムベーハー | ペプチド薬物を経口送達するための医薬製剤 |
| US10568937B2 (en) * | 2016-04-18 | 2020-02-25 | Radius Health, Inc. | Formulations of abaloparatide, transdermal patches thereof, and uses thereof |
| JP2019529506A (ja) * | 2016-09-29 | 2019-10-17 | アレコル リミテッド | 新規の製剤 |
| WO2018065634A1 (en) | 2016-10-07 | 2018-04-12 | Cyprumed Gmbh | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs |
| SG10201609137PA (en) * | 2016-11-01 | 2018-06-28 | Xylonix Ip Holdings Pte Ltd | Gamma-polyglutamic acid and zinc compositions |
| SG10201609131YA (en) | 2016-11-01 | 2018-06-28 | Xylonix Ip Holdings Pte Ltd | Zinc-pga compositions and methods for treating cancer |
| CN109381695A (zh) * | 2017-08-09 | 2019-02-26 | 武汉武药科技有限公司 | 一种门冬氨酸帕瑞肽注射液及其制备方法和用途 |
| KR102665710B1 (ko) | 2017-08-24 | 2024-05-14 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 그 용도 |
| TWI751379B (zh) | 2017-09-21 | 2022-01-01 | 奧孟亞股份有限公司 | 用於遞送胜肽之藥物組合物 |
| JP7005050B2 (ja) * | 2017-10-20 | 2022-01-21 | ノブメタファーマ カンパニー リミテッド | 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物 |
| CN108079280B (zh) * | 2017-12-30 | 2021-06-04 | 陕西慧康生物科技有限责任公司 | 治疗ⅱ型糖尿病的艾塞那肽滴鼻剂 |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
| CN108721598B (zh) * | 2018-07-03 | 2020-06-05 | 北京市新里程医药科技有限公司 | 一种缩宫素原料的制备方法及其药物组合物和制剂 |
| EP3886814B1 (en) | 2018-11-26 | 2025-02-19 | The Procter & Gamble Company | Solid pharmaceutical preparation containing lipoic acid and use thereof |
| CN110251662B (zh) * | 2018-12-12 | 2023-01-31 | 福州市台江区希吉亚健康科技有限公司 | 一种具有减肥作用的药物 |
| CN110251661B (zh) * | 2018-12-12 | 2022-09-16 | 福州市台江区希吉亚健康科技有限公司 | 一种用于治疗糖尿病或者减肥的药物制剂 |
| KR102327750B1 (ko) * | 2018-12-19 | 2021-11-18 | 대화제약 주식회사 | Glp-1 유사체를 포함하는 경구투여용 약제학적 조성물 |
| KR20210137373A (ko) * | 2019-03-08 | 2021-11-17 | 안야 바이오팜 인코포레이티드 | 부갑상샘 호르몬 유사체의 경구 제제 및 치료 |
| GB201906917D0 (en) * | 2019-05-16 | 2019-07-03 | Intract Pharma Ltd | Novel compositions |
| CN112057619A (zh) * | 2019-06-10 | 2020-12-11 | 苏州兰鼎生物制药有限公司 | 一种具有降血糖作用的药物组合物 |
| CN112138148B (zh) * | 2019-06-10 | 2024-04-09 | 苏州兰鼎生物制药有限公司 | 一种生长激素或其类似物的口服药物组合物 |
| WO2020257260A1 (en) | 2019-06-17 | 2020-12-24 | Massachusetts Institute Of Technology | Formulation of peptide loaded liposomes and related applications |
| AU2020334128B2 (en) * | 2019-08-21 | 2025-10-23 | Brain Chemistry Labs | Compositions comprising a metal and L-serine, and uses thereof |
| KR102216578B1 (ko) * | 2019-09-05 | 2021-02-17 | 주식회사 아이큐어비앤피 | 테리파라타이드를 포함하는 경구용 약학 조성물 및 이의 제조방법 |
| CN114364372A (zh) * | 2019-09-09 | 2022-04-15 | 株式会社泰俊制药 | 包含环孢菌素和薄荷醇的纳米乳液眼用组合物及其制备方法 |
| CN112972658B (zh) * | 2019-12-14 | 2024-04-09 | 苏州兰鼎生物制药有限公司 | 一种生长激素或其类似物的口服药物组合物 |
| CN113509544B (zh) * | 2019-12-14 | 2024-04-09 | 苏州兰鼎生物制药有限公司 | 一种具有降血糖作用的药物组合物 |
| CN112972692A (zh) * | 2019-12-14 | 2021-06-18 | 苏州兰鼎生物制药有限公司 | 一种促进肠吸收的药物组合物 |
| CN112972650B (zh) * | 2019-12-14 | 2024-04-09 | 苏州兰鼎生物制药有限公司 | 一种生长抑素或其类似物的口服药物组合物 |
| CN112972656B (zh) * | 2019-12-14 | 2024-04-09 | 苏州兰鼎生物制药有限公司 | 一种胰高血糖素样肽-2或其类似物的口服药物组合物 |
| CN112972659A (zh) * | 2019-12-14 | 2021-06-18 | 苏州兰鼎生物制药有限公司 | 一种特立帕肽或阿巴洛肽的口服药物组合物 |
| CN113171446B (zh) * | 2021-05-06 | 2022-03-29 | 合肥天汇孵化科技有限公司 | 利拉鲁肽组合物及其用途 |
| CN116262134A (zh) * | 2021-12-15 | 2023-06-16 | 联邦生物科技(珠海横琴)有限公司 | 一种稳定的多剂量给药的glp-1受体激动剂的制剂及其制备方法和应用 |
| EP4226918A1 (en) * | 2022-02-15 | 2023-08-16 | Filip Majewski | Pharmaceutical single dosage form for oral delivery of peptides |
| KR102492241B1 (ko) * | 2022-02-25 | 2023-01-30 | 전남대학교산학협력단 | Kitenin의 이량체 형성을 저해하는 펩타이드 및 이의 용도 |
| CN120129529A (zh) * | 2022-04-29 | 2025-06-10 | 鹏跃医药科技有限公司 | 用于鼻內給药的索马鲁肽及其盐的药物組合物 |
| CN115161253B (zh) * | 2022-05-30 | 2022-12-02 | 微康益生菌(苏州)股份有限公司 | 一种保持细胞结构完整性的益生菌灭活方法及其应用 |
| EP4299071A1 (en) * | 2022-07-01 | 2024-01-03 | Adocia | Compositions comprising a peptide or a protein and an acylated amino acid |
| CN114984191B (zh) * | 2022-07-04 | 2022-10-25 | 北京惠之衡生物科技有限公司 | 一种多肽类药物口服递送组合物 |
| CN119907661A (zh) * | 2022-07-05 | 2025-04-29 | G2G生物公司 | 含有司美格鲁肽或其药学上可接受的盐的缓释微球制剂及其制备方法 |
| KR102844771B1 (ko) * | 2022-07-22 | 2025-08-12 | 주식회사 아이큐어비앤피 | 테리파라타이드를 포함하는 골다공증 예방 또는 치료를 위한 경구용 약학적 조성물 및 이의 제조방법 |
| CN116271064A (zh) * | 2022-09-09 | 2023-06-23 | 中山大学·深圳 | 一种促进利拉鲁肽安全渗透肠细胞的辅料组合物 |
| WO2024077409A1 (en) * | 2022-10-09 | 2024-04-18 | Guangzhou Dazhou Biomedicine Ltd. | Oral delivery of therapeutic agents |
| KR102590243B1 (ko) * | 2023-03-13 | 2023-10-20 | 주식회사 에코월드팜 | 수면장애 개선을 위한 l-트립토판 및 키토산을 포함하는 조성물 |
| EP4701625A2 (en) | 2023-04-26 | 2026-03-04 | Vivtex Corporation | Formulation of therapeutic agents for improved permeation |
| WO2025037993A1 (en) * | 2023-08-13 | 2025-02-20 | Filip Majewski | Dosage form for peptide agents |
| CN119454605B (zh) * | 2023-11-30 | 2025-12-19 | 深圳奥礼生物科技有限公司 | 一种实现多肽口服吸收的组合物 |
| CN118001411A (zh) * | 2024-04-09 | 2024-05-10 | 深圳奥礼生物科技有限公司 | 一种肠道吸收组合物 |
| CN118105468B (zh) * | 2024-04-23 | 2024-07-16 | 长春生物制品研究所有限责任公司 | 重组人干扰素α2a栓及制备方法 |
| US12544349B1 (en) | 2024-12-30 | 2026-02-10 | Adocia | Compositions comprising pemvidutide and an acylated amino acid |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK39892D0 (da) | 1992-03-25 | 1992-03-25 | Bernard Thorens | Peptid |
| US5661130A (en) | 1993-06-24 | 1997-08-26 | The Uab Research Foundation | Absorption enhancers for drug administration |
| US5461031A (en) | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
| US5869602A (en) | 1995-03-17 | 1999-02-09 | Novo Nordisk A/S | Peptide derivatives |
| US5866536A (en) | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| US5773647A (en) | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| EP1061946B1 (en) | 1998-02-27 | 2004-04-28 | Novo Nordisk A/S | Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| JP2002506792A (ja) | 1998-02-27 | 2002-03-05 | ノボ ノルディスク アクティーゼルスカブ | Ｎ末端修飾ｇｌｐ−１誘導体 |
| WO1999043706A1 (en) | 1998-02-27 | 1999-09-02 | Novo Nordisk A/S | Derivatives of glp-1 analogs |
| JP2003522099A (ja) | 1998-02-27 | 2003-07-22 | ノボ ノルディスク アクティーゼルスカブ | 遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン |
| ES2235854T3 (es) | 1999-04-05 | 2005-07-16 | Emisphere Technologies, Inc. | Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos. |
| US20020009490A1 (en) * | 1999-12-22 | 2002-01-24 | Benkendorfer Travis R. | Antiviral therapeutic composition and treatment |
| US20010012829A1 (en) * | 2000-01-11 | 2001-08-09 | Keith Anderson | Transepithelial delivery GLP-1 derivatives |
| US20030017195A1 (en) | 2001-07-20 | 2003-01-23 | Samir Mitragotri | Method for oral drug delivery |
| BR122019021416A2 (https=) | 2003-09-19 | 2019-12-21 | ||
| AU2004290983A1 (en) * | 2003-11-19 | 2005-06-02 | Vecta Ltd. | Methods and compositions for the treatment of Helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds |
| EP1696962A2 (en) | 2003-12-18 | 2006-09-06 | Novo Nordisk A/S | Novel glp-1 analogues linked to albumin-like agents |
| ATE461217T1 (de) | 2003-12-18 | 2010-04-15 | Novo Nordisk As | Glp-1-verbindungen |
| CN101115769A (zh) * | 2004-05-19 | 2008-01-30 | 马克西根公司 | 干扰素-α多肽和偶联物 |
| CA2572770A1 (en) | 2004-07-08 | 2006-01-19 | Novo-Nordisk A/S | Polypeptide protracting tags comprising a tetrazole moiety |
| JP2006028031A (ja) * | 2004-07-12 | 2006-02-02 | Ltt Bio-Pharma Co Ltd | 経粘膜吸収用薬物封入ナノ粒子 |
| RU2527893C2 (ru) | 2004-07-19 | 2014-09-10 | Биокон Лимитед | Инсулин-олигомерные конъюгаты, их препараты и применения |
| EP1781257B1 (en) * | 2004-08-13 | 2018-12-19 | Emisphere Technologies, Inc. | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| JP5066448B2 (ja) * | 2004-09-03 | 2012-11-07 | 協和発酵バイオ株式会社 | 口内炎の予防または治療のための組成物および方法 |
| WO2006037810A2 (en) | 2004-10-07 | 2006-04-13 | Novo Nordisk A/S | Protracted glp-1 compounds |
| US8030273B2 (en) | 2004-10-07 | 2011-10-04 | Novo Nordisk A/S | Protracted exendin-4 compounds |
| WO2006082245A1 (en) | 2005-02-07 | 2006-08-10 | Novo Nordisk A/S | Pharmaceutical preparations comprising insulin, zinc ions and a zinc-binding ligand |
| TWI362392B (en) | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| US8603972B2 (en) | 2005-03-18 | 2013-12-10 | Novo Nordisk A/S | Extended GLP-1 compounds |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| WO2007029238A2 (en) | 2005-09-06 | 2007-03-15 | Oramed Pharmaceuticals, Inc. | Methods and compositions for oral administration of proteins |
| WO2007041481A1 (en) * | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
| CN101309668A (zh) * | 2005-11-30 | 2008-11-19 | 健乐克斯医药公司 | 经口吸收的药物制剂和用药方法 |
| GB0525461D0 (en) * | 2005-12-15 | 2006-01-25 | Archimedes Dev Ltd | Pharmaceutical compositions |
| ES2371361T3 (es) | 2005-12-28 | 2011-12-30 | Novo Nordisk A/S | Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones. |
| WO2008023050A1 (en) | 2006-08-25 | 2008-02-28 | Novo Nordisk A/S | Acylated exendin-4 compounds |
| EP2190872B1 (en) | 2007-09-05 | 2018-03-14 | Novo Nordisk A/S | Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| WO2009030771A1 (en) | 2007-09-05 | 2009-03-12 | Novo Nordisk A/S | Peptides derivatized with a-b-c-d- and their therapeutical use |
| US20100292133A1 (en) | 2007-09-05 | 2010-11-18 | Novo Nordisk A/S | Truncated glp-1 derivaties and their therapeutical use |
| TWI394580B (zh) | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
| PE20110543A1 (es) * | 2008-08-15 | 2011-08-04 | Ironwood Pharmaceuticals Inc | Formulacion solida oral que comprende linaclotida, cation de calcio y leucina |
| US20130012454A1 (en) * | 2009-07-06 | 2013-01-10 | Ironwood Pharmaceuticals, Inc. | Orally Disintegrating Compositions of Linaclotide |
| CA2770077A1 (en) | 2009-08-06 | 2011-02-10 | Ironwood Pharmaceuticals, Inc. | Formulations comprising linaclotide |
| JP6016234B2 (ja) | 2009-09-30 | 2016-10-26 | ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー | ビタミンｂ部分構造を持つ粘膜付着性ポリマー |
| US20110311621A1 (en) * | 2010-03-16 | 2011-12-22 | Paul Salama | Pharmaceutical compositions and methods of delvery |
| CN102970864A (zh) | 2010-04-21 | 2013-03-13 | 那挪玛加医药有限公司 | 纳米颗粒药物组合物 |
| MX2012012943A (es) | 2010-05-10 | 2012-11-29 | Novo Nordisk As | Proceso para preparacion de complejos de insulina-cinc. |
| TW201202178A (en) * | 2010-06-04 | 2012-01-16 | Chemo Iberica Sa | Process for producing Aliskiren |
| SI2651398T1 (en) * | 2010-12-16 | 2018-04-30 | Novo Nordisk A/S | SOLID COMPOSITIONS CONTAINING GLP-1 AGONIST AND SOL N- (8- (2-HYDROXYBENZOIL) AMINO) CAPRICULATE ACIDS |
| WO2012098187A1 (en) * | 2011-01-19 | 2012-07-26 | Novo Nordisk A/S | Glp-1 compositions |
| CN103347532A (zh) | 2011-02-04 | 2013-10-09 | 爱奇司治疗公司 | 口服可生物利用肽药物组合物及其方法 |
| EP2696847A1 (en) | 2011-04-14 | 2014-02-19 | Novo Nordisk A/S | Fatty acid acylated amino acids for oral peptide delivery |
| EP2717858B1 (en) * | 2011-06-10 | 2018-08-08 | Aquestive Therapeutics, Inc. | Combination peptide-nanoparticles and delivery systems incorporating same |
| US20130004590A1 (en) | 2011-06-28 | 2013-01-03 | Lin Connie B | Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
| CN111053918A (zh) * | 2011-09-05 | 2020-04-24 | 韩美科学株式会社 | 一种包含干扰素α-缀合物的抗癌用药物组合物 |
| HRP20181447T1 (hr) | 2012-03-22 | 2018-11-02 | Novo Nordisk A/S | Pripravci glp-1 peptida i njihova priprava |
| US20150174076A1 (en) | 2012-06-14 | 2015-06-25 | Entrega, Inc. | Mucoadhesive devices for delivery of active agents |
| JP2016506391A (ja) * | 2012-12-06 | 2016-03-03 | ステルス ペプチドズ インターナショナル インコーポレイテッド | ペプチド治療薬およびその使用方法 |
| CN103948915B (zh) * | 2014-05-05 | 2016-06-22 | 德立唯（北京）生物科技有限公司 | 一种能够提高稳定性和口服疗效的用于预防血栓形成和溶栓的纳豆激酶组合物 |
| ES2630106T3 (es) | 2014-10-07 | 2017-08-18 | Cyprumed Gmbh | Formulaciones farmacéuticas para la administración oral de fármacos peptídicos o proteicos |
-
2014
- 2014-10-07 ES ES14187885.0T patent/ES2630106T3/es active Active
- 2014-10-07 DK DK14187885.0T patent/DK3006045T3/en active
- 2014-10-07 EP EP14187885.0A patent/EP3006045B3/en active Active
-
2015
- 2015-10-07 BR BR112017006957A patent/BR112017006957A2/pt not_active Application Discontinuation
- 2015-10-07 SG SG11201702813VA patent/SG11201702813VA/en unknown
- 2015-10-07 RU RU2017115651A patent/RU2017115651A/ru unknown
- 2015-10-07 EP EP15788340.6A patent/EP3204045B1/en not_active Revoked
- 2015-10-07 KR KR1020177009950A patent/KR20170061140A/ko not_active Withdrawn
- 2015-10-07 CN CN201580054091.XA patent/CN106794252A/zh not_active Withdrawn
- 2015-10-07 WO PCT/EP2015/073196 patent/WO2016055550A1/en not_active Ceased
- 2015-10-07 CA CA2960334A patent/CA2960334A1/en not_active Withdrawn
- 2015-10-07 US US15/517,306 patent/US20170304195A1/en not_active Abandoned
- 2015-10-07 MX MX2017004592A patent/MX2017004592A/es unknown
- 2015-10-07 JP JP2017519568A patent/JP2017531665A/ja active Pending
- 2015-10-07 AU AU2015330016A patent/AU2015330016A1/en not_active Withdrawn
-
2017
- 2017-03-09 ZA ZA2017/01719A patent/ZA201701719B/en unknown
- 2017-03-30 IL IL251462A patent/IL251462A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017531665A5 (https=) | ||
| JP2025179167A5 (https=) | ||
| RU2017115651A (ru) | Фармацевтические составы для пероральной доставки пептидных или белковых лекарственных средств | |
| JP2021520391A5 (https=) | ||
| JP2018529749A5 (https=) | ||
| US10905744B2 (en) | Pharmaceutical formulations for the oral delivery of peptide drugs | |
| CA2963659C (en) | Use of oral octreotride compositions | |
| US12208118B2 (en) | Pharmaceutical compositions for delivery of peptide | |
| FI3634468T3 (fi) | Suun kautta annettavat kiinteät koostumukset | |
| US20180271792A1 (en) | Oral delivery of physiologically active substances | |
| WO2018065634A1 (en) | Pharmaceutical compositions for the nasal delivery of peptide or protein drugs | |
| US20150065423A1 (en) | Rapid acting injectable formulations | |
| TWI821541B (zh) | Pth類似物之口服製劑及治療 | |
| KR102821435B1 (ko) | 동결 건조된 약학적 제제 및 그의 용도 | |
| CN120076788A (zh) | 在非质子极性溶剂中的稳定的左甲状腺素组合物 | |
| JP2019507174A5 (https=) | ||
| EP3419649B1 (en) | Stable pharmaceutical compositions comprising insulin glargine and insulin aspart and methods of preparation thereof | |
| US20120129769A1 (en) | Orally administerable pharmaceutical preparation containing insulin | |
| NZ760995B2 (en) | Pharmaceutical compositions for delivery of peptide | |
| CN119968205A (zh) | 口服多肽组合物及其用途 | |
| HK40096841A (zh) | 一种多肽组合物、药物、药物组合物及其应用 | |
| RU2020127262A (ru) | Твердые композиции, содержащие агонист glp-1, соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты и смазывающее вещество | |
| RU2023128471A (ru) | Твердые композиции, содержащие агонист glp-1, соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты и смазывающее вещество |